CymaBay Therapeutics, Inc.·4

May 22, 5:13 PM ET

Shantharam Harish 4

4 · CymaBay Therapeutics, Inc. · Filed May 22, 2023

Insider Transaction Report

Form 4
Period: 2023-05-22
Shantharam Harish
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-05-22+360,000360,000 total
    Exercise: $8.76Exp: 2033-05-21Common Stock (360,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on May 22, 2024 and vests as to 1/48 of the underlying shares monthly thereafter.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES